Klinische Relevanz von Kontextfaktoren als Auslöser von
                    Placebo- und Nocebo-Effekten bei muskuloskelettalen Schmerzen

Giacomo Rossettini; Elisa Carlino; Marco Testa

doi:10.1055/a-2140-6317

MSK – Muskuloskelettale Physiotherapie, Table of Contents

MSK – Muskuloskelettale Physiotherapie 2023; 27(05): 259-271
DOI: 10.1055/a-2140-6317

Schwerpunkt | Vertiefung

Klinische Relevanz von Kontextfaktoren als Auslöser von Placebo- und Nocebo-Effekten bei muskuloskelettalen Schmerzen

Giacomo Rossettini

,

Elisa Carlino

,

Marco Testa

Abstract

Welche Rolle spielen Kontextfaktoren bei der Therapie? Und wie können sich Therapeut*innen diese zunutze machen? Das Autorenteam gibt in diesem Artikel umfassend Antwort auf diese Fragen. Sicher ist: Über die Modulation der Kontextfaktoren kann der spezifische Therapieeffekt positiv unterstützt werden. Therapeut*innen sollten dies bewusst nutzen.

Full Text

References

Literatur
1 Williams AC, Craig KD. Updating the definition of pain. Pain 2016; 157: 2420-2423
2 Dieppe P. Chronic Musculoskeletal Pain. BMJ 2013; 346: f3146
3 Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol 2012; 26: 183-224
4 Gerdle B, Ghafouri B, Ernberg M. et al. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res 2014; 7: 313-326
5 Iannetti GD, Mouraux A. From the neuromatrix to the pain matrix (and back). Exp Brain Res 2010; 205: 1-12
6 Pelletier R, Higgins J, Bourbonnais D. Is neuroplasticity in the central nervous system the missing link to our understanding of chronic musculoskeletal disorders?. BMC Musculoskelet Disord 2015; 16: 25
7 Blasini M, Corsi N, Klinger R. et al. Nocebo and pain: an overview of the psychoneurobiological mechanisms. Pain Rep 2017; 2: e 585
8 Vase L, Skyt I, Hall KT. Placebo, nocebo, and neuropathic pain. Pain 2016; 157: S98-S105
9 Colagiuri B, Schenk LA, Kessler MD. et al. The placebo effect: from concepts to genes. Neuroscience 2015; 307: 171-90
10 Schedlowski M, Enck P, Rief W. et al. Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev 2015; 67: 697-730
11 Colloca L, Klinger R, Flor H. et al. Placebo analgesia: psychological and neurobiological mechanisms. Pain 2013; 154: 511-514
12 Colloca L, Enck P, DeGrazia D. Relieving pain using dose-extending placebos: a scoping review. Pain 2016; 157: 1590-1598
13 Belcher AM, Ferre S, Martinez PE. et al. Role of placebo effects in pain and neuropsychiatric disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 2017; 17: 30164-1
14 Colloca L, Miller FG. The nocebo effect and its relevance for clinical practice. Psychosom Med 2011; 73: 598-603
15 Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 2014; 84: 623-637
16 Benedetti F, Lanotte M, Lopiano L. et al. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007; 147: 260-271
17 Di Blasi Z, Harkness E, Ernst E. et al. Influence of context effects on health outcomes: a systematic review. Lancet 2001; 357: 757-762
18 Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013; 93: 1207-1246
19 Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015; 16: 403-418
20 Carlino E, Frisaldi E, Benedetti F. Pain and the context. Nat Rev Rheumatol 2014; 10: 348-355
21 Carlino E, Benedetti F. Different contexts, different pains, different experiences. Neuroscience 2016; 338: 19-26
22 Geuter S, Koban L, Wager TD. The cognitive neuroscience of placebo effects: concepts, predictions, and physiology. Annu Rev Neurosci 2017; 40: 167-188
23 Doering BK, Rief W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci 2012; 33: 165-172
24 Buchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron 2014; 81: 1223-1239
25 Shaibani A, Frisaldi E, Benedetti F. Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders. Muscle Nerve 2017; 56: 358-367
26 Schafer SM, Geuter S, Wager TD. Mechanisms of placebo analgesia: a dual- process model informed by insights from cross-species comparisons. Prog Neurobiol 2018; 160: 101-122
27 Lucassen P, Olesen F. Context as a drug: some consequences of placebo research for primary care. Scand J Prim Health Care 2016; 34: 428-433
28 Manchikanti L, Boswell MV, Kaye AD. et al. Therapeutic role of placebo: evolution of a new paradigm in understanding research and clinical practice. Pain Physician 2017; 20: 363-386
29 Carlino E, Pollo A, Benedetti F. Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience. Curr Opin Anaesthesiol 2011; 24: 540-544
30 Geers AL, Miller FG. Understanding and translating the knowledge about placebo effects: the contribution of psychology. Curr Opin Psychiatry 2014; 27: 326-331
31 Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010; 16: 1277-1283
32 Benedetti F, Carlino E, Pollo A. How placebos change the patient’s brain. Neuropsychopharmacology 2011; 36: 339-354
33 Testa M, Rossettini G. Enhance placebo, avoid nocebo: how contextual factors affect physiotherapy outcomes. Man Ther 2016; 24: 65-74
34 Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 2005; 330: 1202-1205
35 Bishop M, Torres-Cueco R, Gay CW. et al. What effect can manual therapy have on a patient’s pain experience?. Pain Manag 2015; 5: 455-464
36 Bialosky JE, Bishop MD, Price DD. et al. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther 2009; 14: 531-538
37 Bialosky JE, Beneciuk JM, Bishop MD. et al. Unraveling the mechanisms of manual therapy: modeling an approach. J Orthop Sports Phys Ther 2018; 48: 8-18
38 Dieppe P, Goldingay S, Greville-Harris M. The power and value of placebo and nocebo in painful osteoarthritis. Osteoarthr Cartil 2016; 24: 1850-1857
39 O’Sullivan P, Caneiro JP, O’Keeffe M. et al. Unraveling the complexity of low back pain. J Orthop Sports Phys Ther 2016; 46: 932-937
40 Balint M. The doctor, his patient, and the illness. Lancet 1955; 265: 683-688
41 Miller FG, Kaptchuk TJ. The power of context: reconceptualizing the placebo effect. J R Soc Med 2008; 101: 222-225
42 Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther 2011; 90: 651-661
43 Colloca L, Lopiano L, Lanotte M. et al. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 2004; 3: 679-684
44 Benedetti F, Maggi G, Lopiano L. et al. Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome. Prevention Treatment 2003; 6: 1-19
45 Benedetti F, Colloca L, Lanotte M. et al. Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull 2004; 63: 203-211
46 Amanzio M, Pollo A, Maggi G. et al. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 2001; 90: 205-215
47 Horing B, Weimer K, Muth ER, Enck P. Prediction of placebo responses: a systematic review of the literature. Front Psychol 2014; 5: 1079
48 Benedetti F, Frisaldi E, Carlino E. et al. Teaching neurons to respond to placebos. J Physiol 2016; 594: 5647-5660
49 Vase L, Amanzio M, Price DD. Nocebo vs. placebo: the challenges of trial design in analgesia research. Clin Pharmacol Ther 2015; 97: 143-150
50 Enck P, Bingel U, Schedlowski M. et al. The placebo response in medicine: minimize, maximize or personalize?. Nat Rev Drug Discov 2013; 12: 191-204
51 Wickramasekera I. A conditioned response model of the placebo effect predictions from the model. Biofeedback Self Regul 1980; 5: 5-18
52 Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol 1985; 40: 1189-1202
53 Bingel U, Wanigasekera V, Wiech K. et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3: 70ra14
54 Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond Ser B Biol Sci 2011; 366: 1859-1869
55 Wager TD, Rilling JK, Smith EE. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303: 1162-1167
56 Bingel U, Lorenz J, Schoell E. et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120: 8-15
57 Eippert F, Bingel U, Schoell ED. et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63: 533-543
58 Lui F, Colloca L, Duzzi D. et al. Neural bases of conditioned placebo analgesia. Pain 2010; 151: 816-824
59 Elsenbruch S, Kotsis V, Benson S. et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain 2012; 153: 382-390
60 Geuter S, Büchel C. Facilitation of pain in the human spinal cord by nocebo treatment. J Neurosci 2013; 33: 13784-13790
61 Petrovic P, Kalso E, Petersson KM. et al. A prefrontal non-opioid mechanism in placebo analgesia. Pain 2010; 150: 59-65
62 Petrovic P, Kalso E, Petersson KM. et al. Placebo and opioid analgesia– imaging a shared neuronal network. Science 2002; 295: 1737-1740
63 Amanzio M, Benedetti F, Porro CA. et al. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp 2013; 34: 738-752
64 Sawamoto N, Honda M, Okada T. et al. Expectation of pain enhances responses to nonpainful Somatosensory stimulation in the anterior Cingulate cortex and parietal operculum/posterior Insula: an event-related functional magnetic resonance imaging study. J Neurosci 2000; 20: 7438-7445
65 Koyama T, McHaffie JG, Laurienti PJ. et al. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 2005; 102: 12950-12955
66 Keltner JR, Furst A, Fan C. et al. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 2006; 26: 4437-4443
67 Kong J, Gollub RL, Polich G. et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 2008; 28: 13354-13362
68 Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked pain potentials. Brain Behav Immun 2006; 20: 219-230
69 Piedimonte A, Guerra G, Vighetti S. et al. Measuring expectation of pain: contingent negative variation in placebo and nocebo effects. Eur J Pain 2017; 21: 874-885
70 Carlino E, Torta DM, Piedimonte A. et al. Role of explicit verbal information in conditioned analgesia. Eur J Pain 2015; 19: 546-553
71 Colloca L, Tinazzi M, Recchia S. et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 2008; 139: 306-314
72 Benedetti F, Pollo A, Lopiano L. et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003; 23: 4315-4323
73 Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; 2: 654-657
74 Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning- activated specific subsystems. J Neurosci 1999; 19: 484-494
75 Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995; 346: 1231
76 Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 1996; 64: 535-543
77 Benedetti F, Amanzio M, Thoen W. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology 2011; 213: 791-797
78 Benedetti F, Amanzio M, Rosato R. et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 2011; 17: 1228-1230
79 Zubieta JK, Bueller JA, Jackson LR. et al. Placebo effects mediated by endogenous opioid activity on mu- opioid receptors. J Neurosci 2005; 25: 7754-7762
80 Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A 2007; 104: 11056-11061
81 Scott DJ, Stohler CS, Egnatuk CM. et al. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007; 55: 325-336
82 Scott DJ, Stohler CS, Egnatuk CM. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008; 65: 220-231
83 Kessner S, Sprenger C, Wrobel N. et al. Effect of oxytocin on placebo analgesia: a randomized study. JAMA 2013; 310: 1733-1735
84 Colloca L, Pine DS, Ernst M. et al. Vasopressin boosts placebo analgesic effects in women: a randomized trial. Biol Psychiatry 2016; 79: 794-802
85 Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain 2014; 155: 921-928
86 Bishop MD, Bialosky JE, Cleland JA. Patient expectations of benefit from common interventions for low back pain and effects on outcome: secondary analysis of a clinical trial of manual therapy interventions. J. Man Manip Ther 2011; 19: 20-25
87 Ferreira PH, Ferreira ML, Maher CG. et al. The therapeutic alliance between clinicians and patients predicts outcome in chronic low back pain. Phys Ther 2013; 93: 470-478
88 Fuentes J, Armijo-Olivo S, Funabashi M. et al. Enhanced therapeutic alliance modulates pain intensity and muscle pain sensitivity in patients with chronic low back pain: an experimental controlled study. Phys Ther 2014; 94: 477-489
89 Wand BM, Tulloch VM, George PJ. et al. Seeing it helps: movement-related back pain is reduced by visualization of the back during movement. Clin J Pain 2012; 28: 602-608
90 Myers SS, Phillips RS, Davis RB. et al. Patient expectations as predictors of outcome in patients with acute low back pain. J Gen Intern Med 2008; 23: 148-153
91 Linde K, Witt CM, Streng A. et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 2007; 128: 264-271
92 Kalauokalani D, Cherkin DC, Sherman KJ. et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) 2001; 26: 1418-1424
93 Sherman KJ, Cherkin DC, Ichikawa L. et al. Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine (Phila Pa 1976) 2010; 35: 1471-1477
94 George SZ, Robinson ME. Preference, expectation, and satisfaction in a clinical trial of behavioral interventions for acute and sub-acute low back pain. J Pain 2010; 11: 1074-1082
95 Skatteboe S, Roe C, Fagerland MW, Granan LP. Expectations of pain and functioning in patients with musculoskeletal disorders: a cross-sectional study. BMC Musculoskelet Disord 2017; 18: 48
96 Kongsted A, Vach W, Axo M. et al. Expectation of recovery from low back pain: a longitudinal cohort study investigating patient characteristics related to expectations and the association between expectations and 3-month outcome. Spine (Phila Pa 1976) 2014; 39: 81-90
97 Goossens ME, Vlaeyen JW, Hidding A. et al. Treatment expectancy affects the outcome of cognitive-behavioral interventions in chronic pain. Clin J Pain 2005; 21: 18-26
98 Wasan AD, Kong J, Pham LD. et al. The impact of placebo, psychopathology, and expectations on the response to acupuncture needling in patients with chronic low back pain. J Pain 2010; 11: 555-563
99 Witt CM, Schützler L, Lüdtke R. et al. Patient characteristics and variation in treatment outcomes: which patients benefit most from acupuncture for chronic pain?. Clin J Pain 2011; 27: 550-555
100 Vase L, Vollert J, Finnerup NB. et al. Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials. Pain 2015; 156: 1795-1802
101 Graz B, Wietlisbach V, Porchet F. et al. Prognosis or “curabo effect?”: physician prediction and patient outcome of surgery for low back pain and sciatica. Spine (Phila Pa 1976) 2005; 30: 1448-1452
102 Darlow B, Fullen BM, Dean S. et al. The association between health care professional attitudes and beliefs and the attitudes and beliefs, clinical management, and outcomes of patients with low back pain: a systematic review. Eur J Pain 2012; 16: 3-17
103 Sit RW, Yip BH, Chan DC. et al. Primary care physicians’ attitudes and beliefs towards chronic low back pain: an Asian study. PLoS One 2015; 10: e0117521
104 Farin E, Gramm L, Schmidt E. The patient-physician relationship in patients with chronic low back pain as a predictor of outcomes after rehabilitation. J Behav Med 2013; 36: 246-258
105 Zangrando F, Piccinini G, Tagliolini C. et al. The efficacy of a preparatory phase of a touch-based approach in treating chronic low back pain: a randomized controlled trial. J Pain Res 2017; 10: 941-949
106 Gardner T, Refshauge K, McAuley J. et al. Patient- led goal setting: a pilot study investigating a promising approach for the Management of Chronic low Back Pain. Spine (Phila Pa 1976) 2016; 41: 1405-1413
107 Gardner T, Refshauge K, Smith L. et al. Physiotherapists’ beliefs and attitudes influence clinical practice in chronic low back pain: a systematic review of quantitative and qualitative studies. J Phys 2017; 63: 132-143
108 Louw A, Zimney K, Landers MR. et al. A randomised controlled trial of ‘clockwise’ ultrasound for low back pain. S Afr J Physiother 2016; 72: 306
109 Bishop MD, Mintken PE, Bialosky JE. et al. Patient expectations of benefit from interventions for neck pain and resulting influence on outcomes. J Orthop Sports Phys Ther 2013; 43: 457-465
110 Diers M, Zieglgänsberger W, Trojan J. et al. Site-specific visual feedback reduces pain perception. Pain 2013; 154: 890-896
111 Groeneweg R, Haanstra T, Bolman CAW. et al. Treatment success in neck pain: the added predictive value of psychosocial variables in addition to clinical variables. Scand J Pain 2017; 14: 44-52
112 Chester R, Jerosch-Herold C, Lewis J. et al. Psychological factors are associated with the outcome of physiotherapy for people with shoulder pain: a multicentre longitudinal cohort study. Br J Sports Med 2018; 52: 269-275
113 Louw A, Puentedura EJ, Reese D. et al. Immediate effects of mirror therapy in patients with shoulder pain and decreased range of motion. Arch Phys Med Rehabil 2017; 98: 1941-1947
114 Abhishek A, Doherty M. Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthr Cartil 2013; 21: 1229-1235
115 Doherty M, Dieppe P. The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthr Cartil 2009; 17: 1255-1262
116 Zou K, Wong J, Abdullah N. et al. Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2016; 75: 1964-1970
117 Coste J, Montel S. Placebo-related effects: a meta-narrative review of conceptualization, mechanisms and their relevance in rheumatology. Rheumatology (Oxford) 2017; 56: 334-343
118 Zhang W, Robertson J, Jones AC. et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008; 67: 1716-1723
119 Bannuru RR, McAlindon TE, Sullivan MC. et al. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med 2015; 163: 365-372
120 White P, Bishop FL, Prescott P. et al. Practice, practitioner, or placebo? A multifactorial, mixed-methods randomized controlled trial of acupuncture. Pain 2012; 153: 455-462
121 Suarez-Almazor ME, Looney C, Liu Y. et al. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res 2010; 62: 1229-1236
122 Street RL, Cox V, Kallen MA. et al. Exploring communication pathways to better health: clinician communication of expectations for acupuncture effectiveness. Patient Educ Couns 2012; 89: 245-251
123 Lu DF, Hart LK, Lutgendorf SK. et al. The effect of healing touch on the pain and mobility of persons with osteoarthritis: a feasibility study. Geriatr Nurs 2013; 34: 314-322
124 Forward JB, Greuter NE, Crisall SJ. et al. Effect of structured touch and guided imagery for pain and anxiety in elective joint replacement patients– a randomized controlled trial: M-TIJRP. Perm J 2015; 19: 18-28
125 Shankland B, Beaton D, Ahmed S. et al. Effects of client-centered multimodal treatment on impairment, function, and satisfaction of people with thumb carpometacarpal osteoarthritis. J Hand Ther 2017; 30: 307-313
126 Nestoriuc Y, Orav EJ, Liang MH. et al. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res 2010; 62: 791-799
127 Fors EA, Landmark T, Bakke Ø. Contextual and time dependent pain in fibromyalgia: an explorative study. BMC Res Notes 2012; 20: 644
128 Chen X, Zou K, Abdullah N, Whiteside N. et al. The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials. Clin Rheumatol 2017; 36: 1623-1630
129 Häuser W, Bartram-Wunn E, Bartram C. et al. Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors. Pain 2011; 152: 1709-1717
130 Mitsikostas DD, Chalarakis NG, Mantonakis LI. et al. Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol 2012; 19: 672-680
131 Denison B. Touch the pain away: new research on therapeutic touch and persons with fibromyalgia syndrome. Holist Nurs Pract 2004; 18: 142-151
132 Kosek E, Rosen A, Carville S. et al. Lower placebo responses after long-term exposure to fibromyalgia pain. J Pain 2017; 18: 835-843
133 Berthelot JM. The placebo effect in rheumatology: new data. Joint Bone Spine 2011; 78: 161-165
134 Häuser W, Bartram C, Bartram-Wunn E. et al. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review. Clin J Pain 2012; 28: 437-451
135 Koog YH, Lee JS, Wi H. Nonspecific adverse events in knee osteoarthritis clinical trials: a systematic review. PLoS One 2014; 9: e111776
136 Reiter-Niesert S, Boers M, Detert J. Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee. Osteoarthr Cartil 2016; 24: 1007-1011
137 Zhang W, Doherty M. Efficacy paradox and proportional contextual effect (PCE). Clin Immunol 2017; 17: 30539
138 Puhl AA, Reinhart CJ, Rok ER. et al. An examination of the observed placebo effect associated with the treatment of low back pain – a systematic review. Pain Res Manag 2011; 16: 45-52
139 Menke JM. Do manual therapies help low back pain? A comparative effectiveness meta-analysis. Spine (Phila Pa 1976) 2014; 39: E463-E472
140 Auer CJ, Glombiewski JA, Doering BK. et al. Patients’ expectations predict surgery outcomes: a meta-analysis. Int J Behav Med 2016; 23: 49-62
141 Müller M, Kamping S, Benrath J. et al. Treatment history and placebo responses to experimental and clinical pain in chronic pain patients. Eur J Pain 2016; 20: 1530-1541
142 Birkhäuer J, Gaab J, Kossowsky J. et al. Trust in the health care professional and health outcome: a meta- analysis. PLoS One 2017; 12: e0170988
143 Linton SJ, Vlaeyen J, Ostelo R. The back pain beliefs of health care providers: are we fear-avoidant?. J Occup Rehabil 2002; 12: 223-232
144 Witt CM, Martins F, Willich SN. et al. Can I help you? Physicians’ expectations as predictor for treatment outcome. Eur J Pain 2012; 16: 1455-1466
145 Mistiaen P, van Osch M, van Vliet L. et al. The effect of patient-practitioner communication on pain: a systematic review. Eur J Pain 2016; 20: 675-688
146 Peerdeman KJ, van Laarhoven AI, Keij SM. et al. Relieving patients’ pain with expectation interventions: a meta-analysis. Pain 2016; 157: 1179-1191
147 Decker S, Wardell DW, Cron SG. Using a healing touch intervention in older adults with persistent pain: a feasibility study. J Holist Nurs 2012; 30: 205-213
148 Wardell DW, Decker SA, Engebretson JC. Healing touch for older adults with persistent pain. Holist Nurs Pract 2012; 26: 194-202
149 Dibbelt S, Schaidhammer M, Fleischer C. et al. Patient-doctor interaction in rehabilitation: the relationship between perceived interaction quality and long-term treatment results. Patient Educ Couns 2009; 76: 328-335
150 Kelley JM, Kraft-Todd G, Schapira L. et al. The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2014; 9: e94207
151 Yakunchikov DY, Olechowski CJ, Simmonds MK. et al. The effect of social observational learning, empathy and Catastrophizing in chronic pain patients during acute pain induction. Pain Med 2017; 18: 871-878
152 Goubert L, Vlaeyen JW, Crombez G. et al. Learning about pain from others: an observational learning account. J Pain 2011; 12: 167-174
153 Jonas WB, Crawford C, Colloca L. et al. To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open 2015; 5: e009655
154 Gu AP, Gu CN, Ahmed AT. et al. Sham surgical procedures for pain intervention result in significant improvements in pain: systematic review and meta-analysis. J Clin Epidemiol 2017; 83: 18-23
155 Laursen J, Danielsen A, Rosenberg J. Effects of environmental design on patient outcome: a systematic review. Health Environ Res Des J 2014; 7: 108-119
156 Iyendo TO, Uwajeh PC, Ikenna ES. The therapeutic impacts of environmental design interventions on wellness in clinical settings: a narrative review. Complement Ther Clin Pract 2016; 24: 174-188
157 Iyendo TO. Exploring the effect of sound and music on health in hospital settings: a narrative review. Int J Nurs Stud 2016; 63: 82-100
158 Nijs J, Roussel N, Paul van Wilgen C. et al. Thinking beyond muscles and joints: therapists’ and patients’ attitudes and beliefs regarding chronic musculoskeletal pain are key to applying effective treatment. Man Ther 2013; 18: 96-102
159 Edwards I, Richardson B. Clinical reasoning and population health: decision making for an emerging paradigm of health care. Physiother Theory Pract 2008; 24: 183-193
160 De Felice M, Ossipov MH. Cortical and subcortical modulation of pain. Pain Manag 2016; 6: 111-120
161 Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002; 99: 443-452
162 Vase L, Petersen GL, Riley JL. et al. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 2009; 145: 36-44
163 Price DD, Riley JL, Vase L. Reliable differences in placebo effects between clinical analgesic trials and studies of placebo analgesia mechanisms. Pain 2003; 104: 715-716
164 Petersen GL, Finnerup NB, Colloca L. et al. The magnitude of nocebo effects in pain: a meta-analysis. Pain 2014; 155: 1426-1434
165 Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344: 1594-1602
166 Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004; 256: 91-100
167 Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; 20: CD003974
168 Klinger R, Flor H. Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment. Handb Exp Pharmacol 2014; 225: 217-235
169 Bishop FL, Coghlan B, Geraghty AW. et al. What techniques might be used to harness placebo effects in non-malignant pain? A literature review and survey to develop a taxonomy. BMJ Open 2017; 7: e015516
170 Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep 2014; 18: 419
171 Carlino E, Pollo A, Benedetti F. The placebo in practice: how to use it in clinical routine. Curr Opin Support Palliat Care 2012; 6: 220-225
172 Klinger R, Colloca L, Bingel U. et al. Placebo analgesia: clinical applications. Pain 2014; 155: 1055-1058
173 Klinger R, Blasini M, Schmitz J. et al. Nocebo effects in clinical studies: hints for pain therapy. Pain Rep 2017; 2: e586
174 Rief W, Shedden-Mora MC, Laferton JA. et al. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med 2017; 15: 4
175 Younger J, Gandhi V, Hubbard E. et al. Development of the Stanford expectations of treatment scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials 2012; 9: 767-776
176 Placebo Competence Team. Bingel U. Avoiding nocebo effects to optimize treatment outcome. JAMA 2014; 312: 693-694
177 Amanzio M, Palermo S, Skyt I. et al. Lessons learned from Nocebo effects in clinical trials for pain conditions and neurodegenerative disorders. J Clin Psychopharmacol 2016; 36: 475-482
178 Wertli MM, Held U, Lis A. et al. Both positive and negative beliefs are important in patients with spine pain: findings from the Occupational and Industrial Orthopaedic Center registry. Spine J 2018; 18: 1463-1474
179 Schenk L, Krimmel SR, Colloca L. Observe to get pain relief: current evidence and potential mechanisms of socially learned pain modulation. Pain 2017; 158: 2077-2081
180 Koban L, Jepma M, Geuter S. et al. What’s in a word? How instructions, suggestions, and social information change pain and emotion. Neurosci Biobehav Rev 2017; 81: 29-42
181 Benedetti F, Amanzio M. The placebo response: how words and rituals change the patient’s brain. Patient Educ Couns 2011; 84: 413-419
182 Benedetti F. Placebo-induced improvements: how therapeutic rituals affect the patient’s brain. J Acupunct Meridian Stud 2012; 5: 97-103
183 Webster RK, Weinman J, Rubin GJ. A systematic review of factors that contribute to nocebo effects. Health Psychol 2016; 35: 1334-1355
184 Booth J, Moseley GL, Schiltenwolf M. et al. Exercise for chronic musculoskeletal pain: a biopsychosocial approach. Musculoskeletal care 2017; 15: 413-421
185 Wijma AJ, Bletterman AN, Clark JR. et al. Patient-centeredness in physiotherapy: what does it entail? A systematic review of qualitative studies. Physiother Theory Pract 2017; 33: 825-840
186 Stevens A, Köke A, van der Weijden T. et al. The development of a patient-specific method for physiotherapy goal setting: a user-centered design. Disabil Rehabil 2018; 40: 2048-2055
187 Liu T. Route of placebo administration: robust placebo effects in laboratory and clinical settings. Neurosci Biobehav Rev 2017; 83: 451-457
188 Howick J, Rees S. Overthrowing barriers to empathy in healthcare: empathy in the age of the internet. J R Soc Med 2017; 110: 352-357
189 Henry SG, Bell RA, Fenton JJ. et al. Communication about chronic pain and opioids in primary care: Impact on patient and physician visit experience. Pain 2018; 159: 371-379
190 Babatunde F, MacDermid J, MacIntyre N. Characteristics of therapeutic alliance in musculoskeletal physiotherapy and occupational therapy practice: a scoping review of the literature. BMC Health Serv Res 2017; 17: 375
191 Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA 2012; 307: 567-568
192 Howick J, Lewith G, Mebius A. et al. Positive messages may reduce patient pain: a meta-analysis. Eur J Intern Med 2017; 11: 31-38
193 Fässler M, Meissner K, Schneider A. et al. Frequency and circumstances of placebo use in clinical practice–a systematic review of empirical studies. BMC Med 2010; 8: 15
194 Baldwin MJ, Wartolowska K, Carr AJ. A survey on beliefs and attitudes of trainee surgeons towards placebo. BMC Surg 2016; 16: 27
195 Wartolowska K, Beard DJ, Carr AJ. Attitudes and beliefs about placebo surgery among orthopedic shoulder surgeons in the United Kingdom. PLoS One 2014; 9: e91699
196 Berthelot JM, Maugars Y, Abgrall M. et al. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine 2001; 68: 65-70
197 Kisaalita N, Staud R, Hurley R. et al. Placebo use in pain management: the role of medical context, treatment efficacy, and deception in determining placebo acceptability. Pain 2014; 155: 2638-2645
198 Hughes J, Greville-Harris M, Graham CA. et al. What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain. J Med Ethics 2017; 43: 867-870
199 Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth 2011; 32: 229-243
200 Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth 2009; 9: 39-47
201 Blease C, Colloca L, Kaptchuk TJ. Are open-label placebos ethical? Informed consent and ethical equivocations. Bioethics 2016; 30: 407-414
202 Alfano M. Placebo effects and informed consent. Am J Bioeth 2015; 15: 3-12
203 Charlesworth JEG, Petkovic G, Kelley JM. et al. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. J Evid Based Med 2017; 10: 97-107
204 Annoni M, Miller FG. Placebo effects and the ethics of therapeutic communication: a pragmatic perspective. Kennedy Inst Ethics J 2016; 26: 79-103
205 Carvalho C, Caetano JM, Cunha L. et al. Open- label placebo treatment in chronic low back pain: a randomized controlled trial. Pain 2016; 157: 2766-2772
206 Bialosky JE, Robinson ME. Placebo disclosure does not result in negative changes in mood or attitudes towards health care or the provider. J Man Manip Ther 2017; 25: 151-159
207 Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol 2016; 15: 736-747
208 Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond Ser B Biol Sci 2011; 366: 1922-1930
209 Linde K, Fässler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond Ser B Biol Sci 2011; 366: 1905-1912
210 Rossettini G, Testa M. Manual therapy RCTs: should we control placebo in placebo control?. Eur J Phys Rehabil Med 2018; 54: 500-501
211 Puhl AA, Reinhart CJ, Doan JB. et al. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation- a systematic review. Spine J 2017; 17: 445-456
212 Cerritelli F, Verzella M, Cicchitti L. et al. The paradox of sham therapy and placebo effect in osteopathy: a systematic review. Medicine 2016; 95: e4728
213 Maddocks M, Kerry R, Turner A. et al. Problematic placebos in physical therapy trials. J Eval Clin Pract 2016; 22: 598-602
214 Frisaldi E, Shaibani A, Benedetti F. Why we should assess Patients’ expectations in clinical trials. Pain Ther 2017; 6: 107-110
215 Peerdeman KJ, van Laarhoven AI, Peters ML. et al. An integrative review of the influence of expectancies on pain. Front Psychol 2016; 7: 1270
216 Laferton JA, Kube T, Salzmann S. et al. Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol 2017; 8: 233
217 Greco CM, Yu L, Johnston KL. et al. Measuring nonspecific factors in treatment: item banks that assess the healthcare experience and attitudes from the patient’s perspective. Qual Life Res 2016; 25: 1625-1634
218 Simmons K, Ortiz R, Kossowsky J. et al. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain 2014; 155: 2229-2235
219 Savvas SM, Zelencich LM, Gibson SJ. Should placebo be used routinely for chronic pain in older people?. Maturitas 2014; 79: 389-400
220 Bingel U, Colloca L, Vase L. Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology 2011; 57: 354-363
221 Nijs J, Apeldoorn A, Hallegraeff H. et al. Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Physician 2015; 18: E333-E346
222 Osani MC, Bannuru RR. What clinicians should know about differential placebo effects. J Comp Eff Res 2016; 5: 289-296